GIP and type 2 diabetes mellitus: GLP-1 synergizes with GIP to promote metabolic homeostasis, prevent hyperglycemia and hypoglycemia, attenuate dyslipidemia, and reduce the risk of cardiovascular disease in patients with T2DM and obesity.